BRAINLIFE Brain Tumor Medical Database

Treatment > Immunotherapy


38th ASCO Annual Meeting, Orlando FL, May 18-21, 2002. Abstract No. 289 (Animal Study)


Meeting Abstract

Reovirus oncolysis in medulloblastoma is effective in vivo and safe in rodents and primates

Peter A Forsyth, Wen Qing Yang, Donna Senger, Huong Muzik, Zhong Q Shi, Penny Brasher, Richard Dyck

Univ of Calgary & Tom Baker Cancer Ctr, Calgary, AB, Canada

Introduction. Medulloblastoma (MB) is a highly malignant childhood brain tumor. 
Reovirus is not known to cause disease in human adults and usurps activated Ras pathways to produce its dramatic oncolytic effect. 
Since Ras may be activated in MB this could be a promising new treatment for MB. 
In this study we tested 1) the ability of reovirus to infect/kill MB in vitro & in vivo and 2) safety of intracerebral (IC) injection of reovirus in nude mice, Fisher rats and 3) cynomolgous monkeys. 

Methods/Results. MB cell lines (eg. Daoy, TE671, MB from ptc -/+ mice, Daoy+Trk) were infected/killed by reovirus. 
Ras pulldown assays correlated with susceptibility. 
TrkC-transfected MBs (Daoy+Trk)+ NT3 were 50% more susceptible than parental Daoy. 
Reovirus efficacy in vivo was assessed in nude mice with Daoy implanted orthotopically and 20 days later live (LV;N=8) or dead virus (DV;N=8;control) administered IC. 
Mdn survival of LV group (>160 D) was longer than DV group (70 D; p=0.0003). 
We next tested reovirus' neuro-toxicity administrated IC using histology (in nude mice/rats/cynomolgous monkeys) and behavior [using the Morris Water Maze Task (MWMT)in nude mice/rats]. 
Monkeys remained well/afebrile, minimal pathological changes IC and no diffuse encephalitis. 
Mice/rats remained well/gained weight and had MWMT scores equal to controls; rodent histology is pending. 

Conclusions. Oncolytic treatment with reovirus might be an effective treatment for MB. 
The dose/schedule/route of administration should be optimized. 
Direct injection of reovirus IC appears to be safe in two different rodent species and in a primate (cynomologous monkeys) species.

© Copyright 2002 American Society of Clinical Oncology

Source: http://www.asco.org/ac/1,1003,_12-002324-00_18-002002-00_19-00289-00_29-00A-00_42-00ONeill-00_43-00-00_44-00-00_45-00
Author-00_46-00Title-00_47-00Title-00_48-00and-00_49-00and,00.asp?cat=CNS+Tumors&parent=CENTRAL+NERVOUS+SYSTEM+TUMORS
&returnpid=2323


 

This website is certified by Health On the Net Foundation. Click to verify. HOMECURRENT NEURO-ONCOLOGYGLIOBLASTOMA REPORTSBRAIN TUMOR MEDICAL DATABASE SERVICES TREATMENT OPTIONS FOR GLIOBLASTOMA
DATABASE by Section: Classification | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Management | Prognosis | Psychosocial Aspects | Stem Cells | Treatment
DATABASE by Tumor: Glioblastoma | Medulloblastoma | Other TumorsSERVICES: About BrainLife | Children's Corner | Dedication | E-mail Alerts | Journals | Privacy Policy | Publications | Search | SiteMap
This site complies with the HONcode standard for trustworthy health information: verify here bottom